No Detail Found!

Hereditary Hemorrhagic Telangiectasia and the Anesthesiologist.

Author(s)
Sandeep Kumar Kar Department of Cardiac Anesthesiology, Institute of Postgraduate Medical Education & Research, Kolkata, India
Tanmoy Ganguly Department of Cardiac Anesthesiology, Institute of Postgraduate Medical Education & Research, Kolkata, India
Abstract
Osler-Weber-Rendu disease (OWRD) or Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant disorder that causes muco-cutanesous and visceral vascular dysplasia and results in increased tendency for bleeding. Patients with HHT presenting with continuous bleeding pose a serious problem to the Anesthesiologist .Pre-existing anemia due to recurrent bleeding is common and sudden decompensation may lead to heart failure. Uncontrolled bleeding may occur from skin lesions during patient positioning and transport. Epistaxis may lead to aspiration of blood into trachea causing pulmonary edema. Intravenous access may be difficult. Sudden change in blood pressure may cause bleeding from arteriovenous malformations (AVMs) anywhere in the body, most serious of which is from cerebral AVM. Gastric distension may occur from ingested blood and may cause reflux and aspiration during induction. Any instrumentation including laryngoscopy and intubation, nasogastric tube insertion, urinary catheterization should be carried out with utmost caution as bleeding may occur from undetected lesions. Management include blood transfusion, antifibrinolytics and surgical hemostasis. Anesthesia strategy should include rapid sequence induction and controlled hypotension.
Publication Details
Page(s) 387-392
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 21, Issue: 3, Year: 2017

Request the full text from PASTIC

References
PeeryWH., .Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease),Am J Med 82 989 -97
GuttmacherAE,MarchukDA,WhiteRI, .Hereditary hemorrhagic telangiectasia,1995 Oct 5 918 -24
ShovlinCL,GuttmacherAE,BuscariniE,FaughnanME,HylandRH,WestermannCJ, .Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome),2000 Mar 6 66 -7
SharathkumarAA,ShapiroA, 2008.Hereditary haemorrhagic telangiectasia,Haemophilia 01774 2516 -80
PorteousME,BurnJ,ProctorSJ, .Hereditary haemorrhagic telangiectasia: a clinical analysis,J Med Genet 29 527 -530
GoulartAP,MoroET,GuastiVM,ColaresRF, 2009.Anesthetic management of a patient with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome),Case report. Rev Bras Anestesiol 59 74 -8
KjeldsenAD,VaseP,GreenA, .Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients,J Intern Med 245 31 -9
SuttonH, 1864.Epistaxis as an indication of impaired nutrition, and of degeneration of the vascular system,Med Mirror 1 769 -81
RenduH, 1896.Epistaxis repetees chez un sujet porteur de petits angiomes cutanes et muquez,Gazette des Hopitaux Civils et Militaires 135 1322 -3
OslerW.,On, 1901.a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes,Bull Johns Hopkins Hosp 12 333 -7
1907.Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages,Lancet 2 160 -2
1909.Multiple hereditary telangiectases causing hemorrhage (hereditary hemorrhagic telangiectasia),Bull Johns Hopkins Hosp 20 63 -73
NandaS,BhattSP, .Hereditary hemorrhagic telangiectasia: epistaxis and hemoptysis,CMAJ. 2009 Apr 10 838 -
ShovlinCL,LetarteM., .Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms,Thorax 54 714 -29
Ten DijkeP,HillCS, 2004.New insights into TGF-beta-Smad signalling,Trends Biochem Sci 29 265 -73
WranaJL,AttisanoL,WieserR,VenturaF,MassagueJ, .Mechanism of activation of the TGF-beta receptor,1994 Aug 4 341 -7
SchmiererB,HillCS, 2007.TGFbetaSMAD signal transduction: molecular specificity and functional flexibility,Nat Rev Mol Cell Biol 8 970 -82
CirulliA,LisoA,D'OvidioF,MesticeA,PasculliG,GallitelliM, 2003.Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia,Acta Haematol 110 29 -32
XuB,WuYQ,HueyM,ArthurHM,MarchukDA,HashimotoT, 2004.Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain,J Cereb Blood Flow Metab 24 237 -44
McAllisterKA1,GroggKM,JohnsonDW,GallioneCJ,BaldwinMA,JacksonCE, .Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1,1994 Dec;8 345 -51
AbdallaSA,LetarteM., 2006.Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease,J Med Genet. Feb 43 97 -110
McDonaldMT,PapenbergKA,GhoshS,GlatfelterAA,BieseckerBB,HelmboldEA, .A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34,1994 Feb;6 197 -204
ShovlinCL,HughesJM,TuddenhamEG,TemperleyI,PerembelonYF,ScottJ, .A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3,1994 Feb;6 205 -9
JohnsonDW,BergJN,BaldwinMA,GallioneCJ,MarondelI,YoonSJ, 1996.Mutations in the activin receptorlike kinase 1 gene in hereditary haemorrhagic telangiectasia type 2,Nat Genet 13 189 -95
JohnsonDW,BergJN,GallioneCJ,McAllisterKA,WarnerJP,HelmboldEA, .A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12,1995 Aug;5 21 -8
ColeSG,BegbieME,WallaceGM,ShovlinCL,J MedGenet, .A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5, 42 577 -82
Bayrak-ToydemirP,McDonaldJ,AkarsuN,ToydemirRM,CalderonF,TuncaliT,Am J Med GenetA., 2006.A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7, 140 2155 -62
GallioneCJ,RepettoGM,LegiusE,RustgiAK,SchelleySL,TejparS, .A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4),Lancet. 2004 Mar 363 852 -9
GallioneC,AylsworthAS,BeisJ,BerkT,BernhardtB,ClarkRD, .Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome,Am J Med Genet A. 2010 Feb;152A(2) 33206 333 -9
IyerNK,BurkeCA,LeachBH,ParambilJG, 2009.SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia,Thorax 129932 745 -6
HarrisonRE,FlanaganJA,SankeloM,AbdallaSA,RowellJ,MachadoRD, .Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia,J Med Genet 40 865 -71
TrembathRC,ThomsonJR,MachadoRD,MorganNV,AtkinsonC,WinshipI, .Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia,2001 Aug 2 325 -34
FaughnanME,PaldaVA,Garcia-TsaoG,GeisthoffUW,McDonaldJ,ProctorDD, 2009.International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia,J Med Genet 069013 73 -87
SchoenFJ,CotranRS,VinayK, 1994.,Robbins Pathologic Basis of Disease. 5th. WB Saunders 509 -
PlauchuH,de ChadarevianJP,BideauA,RobertJM, .Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population,Am J Med Genet 32 291 -297
BergJ,PorteousM,ReinhardtD,GallioneC,HollowayS,UmasuntharT, .Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations,J Med Genet 40 585 -90
IngrossoM,SabbàC,PisaniA,PrincipiM,GallitelliM,CirulliA, .Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study,Endoscopy 36 1074 -9
KjeldsenAD,KjeldsenJ, 2000.Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia,Am J Gastroenterol 95 415 -8
SabbàC,PasculliG,LenatoGM,SuppressaP,LastellaP,MemeoM, .Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers,J Thromb Haemost. 2007 Jun;5 1149 -57
VaseP,HolmM,Arendrup H, 1985.Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia,Acta Med Scand 218 105 -9
HaitjemaT,DischF,OvertoomTT,WestermannCJ,LammersJW, 1995.Screening family members of patients with hereditary hemorrhagic telangiectasia,Am J Med 99 519 -24
FulbrightRK,ChaloupkaJC,PutmanCM,SzeGK,MerriamMM,LeeGK, 1998.MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations,AJNR Am J Neuroradiol 19 477 -84
BosslerAD,RichardsJ,GeorgeC,GodmilowL,GangulyA, 2006.Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype,Hum Mutat 27 667 -75
MatsubaraS,MandziaJL,ter BruggeK,WillinskyRA,FaughnanME, 2000.Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia,AJNR Am J Neuroradiol 21 1016 -20
MemeoM,Stabile IanoraAA,ScardapaneA,BuonamicoP,SabbaC, 2004.Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings,Abdom Imaging 29 211 -20
BoyerH,FernandesP,DuranO,HunterD,GodingG, .Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study,2011 JulAug;1 10 319 -23
MortuaireG,BouteO,HatronPY,ChevalierD, .Pilot study of submucosal radiofrequency for epistaxis in hereditary hemorrhagic telangiectasia,Rhinology 10 355 -60
DheyauldeenS,Ostertun GeirdalA,OsnesT,VartdalLS,DollnerR., .Bevacizumab in hereditary hemorrhagic telangiectasiaassociated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose,Laryngoscope 10 1210 -4
PauH,CarneyAS,MurtyGE, 2001.Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations,Clin Otolaryngol Allied Sci 26 93 -8
StrotherCM,NewtonTH, 1976.Percutaneous embolisation to control epistaxis in Rendu-Osler-Weber disease,Arch Otolaryngol 102 58 -60
HarriesPG,BrockbankMJ,ShakespearePG,CarruthJA, 1997.Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser,J Laryngol Otol. Nov 111 1038 -41
WernerA,BäumlerW,ZietzS,KühnelT,HohenleutnerU,LandthalerM., 2008.Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm),Lasers Med Sci 23 385 -91
Van CutsemE,RutgeertsP,VantrappenG, .Treatment of bleeding gastrointestinal vascular malformations with oestrogenprogesterone,Lancet. 1990 Apr 335 953 -5
MassoudOI,YoussefWI,MullenKD, 2004.Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis,C. J Clin Gastroenterol 38 377 -9
ShovlinCL,WinstockAR,PetersAM,JacksonJE,HughesJM, 1995.Medical complications of pregnancy in hereditary haemorrhagic telangiectasia,QJM 88 879 -87
WhiteRI,PollakJS,WirthJA, .Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy,1996 NovDec;7 787 -804
HadjipanayisCG,LevyEI,NiranjanA,FirlikAD,KondziolkaD,FlickingerJC, .Stereotactic radiosurgery for motor cortex region arteriovenous malformations,Neurosurgery 48 70 -6
LevyEI,NiranjanA,ThompsonTP,ScarrowAM,KondziolkaD,FlickingerJC, 2000.Radiosurgery for childhood intracranial arteriovenous malformations,Neurosurgery 47 834 -41
Dupuis-GirodS,ChesnaisAL,GinonI,DumortierJ,SaurinJC,FinetG, 2010.Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study,Liver Transpl 10 340 -7
HillertC,BroeringDC,GundlachM,KnoefelWT,IzbickiJR,RogiersX, .Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation,2001 Mar;7 266 -8
LerutJ,OrlandoG,AdamR,SabbàC,PfitzmannR,KlempnauerJ, 2006.Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry,Ann Surg 244 4 -62
MitchellA,AdamsLA,MacquillanG,TibballsJ,Vanden DriesenR, 2008.Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia,Liver Transpl 10 210 -3
CherifH,KarlssonT., 2014.Combination treatment with an erythropoiesisstimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia,Ups J Med Sci 955619 350 -3
GaillardS,Dupuis-GirodS,BoutitieF,RivièreS,MorinièreS,HatronPY, 2014.Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease,J Thromb Haemost 10 1494 -502
Morales-AnguloC1,Pérez del MolinoA,ZarrabeitiaR,FernándezA,SanzRodríguezF,BotellaLM, 2007.[Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid],[Article in Spanish] Acta Otorrinolaringol Esp 58 129 -32
KorzenikJR,TopazianMD,WhiteR, .Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid,1994 Nov 2 1236 -
Fernandez-LA,Garrido-MartinEM,Sanz-RodriguezF,RamirezJR,Morales-AnguloC,ZarrabeitiaR, 2007.Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells,Thromb Haemost 97 254 -62
0

Citations

0

Downloads

181

Views